<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Stefan</forename><surname>Vordenbäumen</surname></persName>
							<email>stefan.vordenbaeumen@med.uni-duesseldorf.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department Rheumatology</orgName>
								<orgName type="institution">Hiller Research Unit Rheumatology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Heinrich-Heine-University</orgName>
								<address>
									<addrLine>Moorenstr. 5</addrLine>
									<postCode>40225</postCode>
									<settlement>Düsseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Angelika</forename><surname>Lueking</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Petra</forename><surname>Budde</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hans-Dieter</forename><surname>Zucht</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Heike</forename><surname>Goehler</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ralph</forename><surname>Brinks</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department Rheumatology</orgName>
								<orgName type="institution">Hiller Research Unit Rheumatology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Heinrich-Heine-University</orgName>
								<address>
									<addrLine>Moorenstr. 5</addrLine>
									<postCode>40225</postCode>
									<settlement>Düsseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rebecca</forename><surname>Fischer-Betz</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department Rheumatology</orgName>
								<orgName type="institution">Hiller Research Unit Rheumatology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Heinrich-Heine-University</orgName>
								<address>
									<addrLine>Moorenstr. 5</addrLine>
									<postCode>40225</postCode>
									<settlement>Düsseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jutta</forename><surname>Richter</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department Rheumatology</orgName>
								<orgName type="institution">Hiller Research Unit Rheumatology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Heinrich-Heine-University</orgName>
								<address>
									<addrLine>Moorenstr. 5</addrLine>
									<postCode>40225</postCode>
									<settlement>Düsseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ellen</forename><surname>Bleck</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department Rheumatology</orgName>
								<orgName type="institution">Hiller Research Unit Rheumatology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Heinrich-Heine-University</orgName>
								<address>
									<addrLine>Moorenstr. 5</addrLine>
									<postCode>40225</postCode>
									<settlement>Düsseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jacqueline</forename><surname>Detert</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hans-Eckhard</forename><surname>Langer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Anne</forename><surname>Sörgel</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department Rheumatology</orgName>
								<orgName type="institution">Hiller Research Unit Rheumatology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Heinrich-Heine-University</orgName>
								<address>
									<addrLine>Moorenstr. 5</addrLine>
									<postCode>40225</postCode>
									<settlement>Düsseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gerd-Rüdiger</forename><surname>Burmester</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Schulz-Knappe</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Matthias</forename><surname>Schneider</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department Rheumatology</orgName>
								<orgName type="institution">Hiller Research Unit Rheumatology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Heinrich-Heine-University</orgName>
								<address>
									<addrLine>Moorenstr. 5</addrLine>
									<postCode>40225</postCode>
									<settlement>Düsseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">1622F74BA621255CE029030313253709</idno>
					<idno type="DOI">10.1186/s13075-016-1135-6</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:49+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Rheumatoid arthritis</term>
					<term>Autoantibody</term>
					<term>Biomarker</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: The aim was to identify novel diagnostic autoantibody candidates for rheumatoid arthritis (RA) by comprehensive screening for autoreactivity.</s><s>Method: We incubated 5892 recombinant proteins coupled to fluorescent beads, with patients' sera for the detection of IgG-autoantibodies in three independent patient cohorts: A (n = 72 patients with established RA); B/B-(n = 116 patients with early RA (B) and n = 51 CCP-negative patients with early RA from B (B-)); and C (n = 184 patients with early seronegative RA), in comparison to matched healthy controls.</s><s>Intersects of significantly increased autoantibodies as determined by the Mann-Whitney test were sought.</s><s>Result: Screening of 5892 antigens in RA cohorts A and B, or the seronegative cohorts B-and C revealed intersects of 23 and 13 significantly increased autoantibodies, respectively.</s><s>Reactivity to three antigens was increased in all cohorts tested: N-acetylglucosamine-1-phosphate transferase, gamma subunit (GNPTG), heterogeneous nuclear ribonucleoprotein A1-like 2 (HNRNPA1), and insulin-like growth factor binding protein 2 (IGFBP2).</s><s>Conclusions: Comprehensive sequential screening for autoantibodies reveals novel candidates for diagnostic markers in both seropositive and seronegative RA and suggests new fields of research into the pathogenesis of RA.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease characterized by destruction of cartilage and bone.</s><s>RA pathogenesis features numerous autoimmune processes such as autoreactive T cells and the formation of autoantibodies <ref type="bibr" target="#b0">[1]</ref>.</s><s>Amongst the autoantibodies present in RA sera, rheumatoid factor (RF) and antibodies against citrullinated peptides (ACPA) have emerged as important diagnostic and prognostic markers <ref type="bibr" target="#b1">[2]</ref>, although a range of other autoantibodies have been identified <ref type="bibr" target="#b2">[3]</ref>.</s><s>Evidence is accumulating that RF and ACPA are directly involved in the pathogenesis of the disease <ref type="bibr" target="#b3">[4]</ref>, potentially even prior to the occurrence of synovial inflammation <ref type="bibr" target="#b4">[5]</ref>.</s></p><p><s>Despite progress in the serologic diagnosis of RA introduced by the detection of these antibodies, a considerable number of patients with RA do not display RF and/or ACPA <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7]</ref>.</s><s>In these cases, the diagnosis of RA relies heavily upon clinical presentation and imaging procedures.</s><s>Thus, identification of reliable additional markers to recognize RF/ACPA-negative RA and to further ascertain the diagnosis of RF/ACPA-positive RA is desirable.</s></p><p><s>We adopted a multiplex bead-based approach to sequentially screen sera from three independent patient cohorts: cohort A, patients with established RA; cohort B, patients with early RA; and cohort C, patients with seronegative RA) for the presence of autoantibodies to over 5800 human antigens, aiming to (1) retrieve a collection of candidates for future diagnostic assay development, and (2) gain new insights into the pathogenesis of RA.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sample cohorts and autoantibody identification strategy</head><p><s>In order to identify potential novel diagnostic autoantibodies, antibody profiles of serum samples from different RA patient cohorts were sequentially compared to healthy controls.</s><s>Healthy controls were chosen in an age-adjusted and sex-adjusted manner from specimens from blood donors of the Bavarian Red Cross, Germany or collected from healthy individuals after the exclusion of rheumatic diseases from a community screening program.</s><s>Patient cohorts were as follows.</s><s><ref type="bibr">Cohort</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Multiplex bead-based autoantibody detection</head><p><s>We produced 5892 recombinant antigens in Escherichia coli and purified them.</s><s>Five cDNA libraries originating from different human tissues (fetal brain, colon, lung, liver, Cd4 induced and non-induced T cells) were used for the recombinant production of human antigens.</s><s>All of these cDNA libraries were oligo(dT)-primed, containing the coding region for an N-terminally located hexahistidine-tag and were under transcriptional control of the lactose inducible promoter from E. coli <ref type="bibr" target="#b8">[9]</ref>.</s><s>Sequence integrity of the cDNA libraries was confirmed by 5' DNA sequencing.</s><s>Additionally, expression clones representing the full-length sequence derived from the human ORFeome collection <ref type="bibr" target="#b9">[10]</ref> were included.</s><s>Individual antigens were designed in silico, synthesized chemically (Life Technologies, Carlsbad, USA) and cloned into the expression vector pQE30-NST fused to the coding region for the N-terminal-located His6-tag.</s><s>Of the antigens, 73 % were produced by cDNA library expression clones, 24 % of the antigens derive from clones of the human ORFeome collection and 3 % of the antigens were based on in silico design.</s></p><p><s>Recombinant gene expression was performed in E. coli SCS1 cells carrying plasmid pSE111 for improved expression of human genes <ref type="bibr" target="#b10">[11]</ref>.</s><s>Cells were cultivated in 200 ml auto-induction medium (Overnight Express autoinduction medium, Merck, Darmstadt, Germany) overnight and harvested by centrifugation.</s><s>Bacterial pellets were lysed by resuspension in 15 ml lysis buffer (6 M guanidinium-HCl, 0.1 M NaH 2 PO 4 , 0.01 M Tris-HCl, pH 8.0).</s><s>Soluble proteins were affinity-purified after binding to Protino® Ni-IDA 1000 Funnel Column (Macherey-Nagel, Düren, Germany).</s><s>Columns were washed with 8 ml washing buffer (8 M urea, 0.1 M NaH 2 PO 4 , 0.01 M Tris-HCl, pH 6.3).</s><s>Proteins were eluted in 3 ml elution buffer (6 M urea, 0.1 M NaH 2 PO 4 , 0.01 M Tris-HCl, 0.5 % (w/v) trehalose pH 4.5).</s><s>Each protein preparation was transferred into 2D-barcoded tubes, lyophilized and stored at -20 °C.</s></p><p><s>In this study, twenty different bead-based arrays containing up to 384 different proteins were used.</s><s>For production of bead-based arrays (BBA), the proteins were coupled to magnetic carboxylated color-coded beads (MagPlex™ microspheres, Luminex Corporation, Austin, TX, USA).</s><s>The manufacturer's protocol for coupling proteins to MagPlex™ microspheres was adapted to use liquid handling systems.</s><s>A semi-automated coupling procedure of one BBA encompassed 384 single, separate coupling reactions, which were carried out in four 96-well plates.</s><s>For each single coupling reaction, up to 12.5 μg antigen and 8.8 × 10 5 MagPlex™ beads of one color region (ID) were used.</s><s>All liquid handling steps were carried out by either an eight-channel pipetting system (Starlet, Hamilton Robotics, Bonaduz, Switzerland) or a 96-channel pipetting system (Evo Freedom 150, Tecan, Männderdorf, Switzerland).</s><s>For semi-automated coupling, antigens were dissolved in H 2 O, and aliquots of 60 microliters were transferred from 2D barcode tubes to 96-well plates.</s><s>MagPlex™ microspheres were homogeneously resuspended and each bead ID was transferred in one well of a 96-well plate.</s><s>The 96-well plates containing the microspheres were placed on a magnetic separator (LifeSep™, Dexter Magnetic Technologies Inc., Elk Grove Village, USA) to sediment the beads for washing steps and on a microtiter plate shaker (MTS2/4, IKA) to facilitate permanent mixing for incubation steps.</s></p><p><s>For coupling, the microspheres were washed three times with activation buffer (100 mM NaH 2 PO 4 , pH 6.2) and resuspended in 120 μl activation buffer.</s><s>To obtain reactive sulfo-NHS-ester intermediates, 15 μl 1-ethly-3-(3-dimethlyaminopropyl) carbodiimide (50 mg/ml) and 15 μl N-hydroxy-succinimide (50 mg/ml) were applied to microspheres.</s><s>After 20 minutes incubation (900 rpm, room temperature (RT)) the microspheres were washed three times with coupling buffer (50 mM MES, pH 5.0) and resuspended in 65 μl coupling buffer.</s><s>Immediately, 60 μl antigen solution was added to reactive microspheres and coupling took place over 120 minutes under permanent mixing (900 rpm, RT).</s><s>After three wash cycles using washing buffer (PBS, 0.1 % Tween20) coupled beads were resuspended in blocking buffer (PBS, 1 % BSA, 0.05 % ProClin300), incubated for 20 minutes (900 rpm, RT) and then transferred to be maintained at 4-8 °C for 12-72 h.</s></p><p><s>To monitor the assay performance various proteins were used as control proteins and coupled individually to microspheres as described for antigens.</s><s>Human and mouse IgG (Sigma-Aldrich, St. Louis, USA) were used to control the reactivity of the detection antibodies, BSA (Sigma-Aldrich) to monitor the background and E. coli lysate to detect serum antibodies directed against E. coli proteins.</s><s>For coupling reaction control 10 μg, 25 μg, 100 μg and 200 μg human IgG, 200 μg mouse IgG, 1 μg BSA and 500 μg E. coli proteins were used, respectively.</s><s>A bead mix of a multiplex BBA was generated by pooling 384 antigen-coupled beads together with control proteincoupled beads.</s><s>The BBA was stored at 4-8 °C until use.</s></p><p><s>Serum samples were transferred to 2D barcode tubes and a 1:100 serum dilution was prepared with assay buffer (PBS, 0.5 % BSA, 10 % E. coli lysate, 50 % Low-Cross buffer (Candor Technologies, Nürnberg, Germany)) in 96-well plates.</s><s>The serum dilutions were first incubated for 20 minutes to neutralize any human IgG eventually directed against E. coli proteins.</s><s>The BBA was sonicated for 5 minutes and the bead mix was distributed in 96-well plates.</s><s>After three wash cycles with washing buffer (PBS, 0.05 % Tween20) serum dilutions (50 μl) were added to the bead mix and incubated for 20 h (900 rpm, 4-8 °C).</s><s>Supernatants were removed from the beads by three wash cycles, and secondary R-phycoerythrinlabeled antibody (5 μg/ml, goat anti-human, Dianova, Hamburg, Germany) was added for a final incubation of 45 minutes (900 rpm, RT).</s><s>The beads were washed three times with washing buffer (PBS, 0.1 % Tween20) and resuspended in 100 μl sheath fluid (Luminex Corporation).</s><s>Subsequently, beads were analyzed in a FlexMap3D device for fluorescent signal readout (DD gate 7.500-15.000;</s><s>sample size: 80 μl; 1000 events per bead ID; timeout 60 sec).</s><s>The binding events were displayed as median fluorescence intensity (MFI).</s><s>Measurements were disregarded when low numbers of bead events (&lt;30 beads) were counted per bead ID.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Our antigen prioritization approach was sequential performance of the Mann-Whitney test to identify intersects of significantly upregulated markers in the patient cohorts compared to matched healthy controls.</s><s>For data preprocessing and normalization, if fewer than 30 beads were counted for a specific antigen, the corresponding MFI value was set to missing.</s><s>Samples or antigens were discarded from further analysis if either a patient sample or an antigen had &gt;20 % missing values.</s><s>In total, six patients and 1.5 % of antigens tested were discarded because of &gt;20 % missing values.</s><s>Prior to normalization, MFI values were log2-transformed.</s><s>Quantile normalization was used to normalize data on each individual plate by BBA according to <ref type="bibr" target="#b11">[12]</ref>.</s><s>A missing MFI value for an antigen was replaced by the respective median value across all samples for this specific antigen.</s><s>Replacement of the data by median imputed values was necessary for &lt;0.25 % without notable accumulation in certain antigens.</s><s>The target variable for all statistical work was the MFI of the detection antibody.</s></p><p><s>Antigens with an upregulated MFI and fold change ≥1 were further considered.</s><s>The fold change was calculated as the ratio of median MFI of cases vs. controls.</s><s>In each cohort, receiver operating characteristic (ROC) analyses were subsequently applied to calculate sensitivity at predefined 90 % specificity in comparison to respective matched healthy controls.</s><s>The statistical software R (version 2.14.2 (2012-02-29)) [http://www.r-project.org] was used for all analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Candidate autoantibody identification in patients with RA</head><p><s>Comparison of autoreactivity to 5892 antigens in sera from 72 patients with established RA (cohort A) and 116 therapynaive patients with early RA (cohort B) resulted in an intersect of 23 antigens with an individual p value &lt;0.05 and fold change &gt;1 (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s>Fold changes ranged from 1.1 to 2.7 as detailed in Table <ref type="table" target="#tab_1">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Candidate autoantibody identification in seronegative patients with RA</head><p><s>In order to more specifically assess autoantibodies in seronegative RA, intersects of significantly increased autoantibodies in the seronegative subgroup of cohort B (termed B-) and an independent therapy-naïve cohort of 184 seronegative patients with RA (cohort C) was sought, resulting in 13 antigenic targets.</s><s>Fold changes ranged from 1.1 to 1.8 as outlined in Table <ref type="table" target="#tab_3">2</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Candidate autoantibody identification in all cohorts</head><p><s>Significantly increased autoantibodies in all cohorts were then identified resulting in diverse intersects as shown in Fig. <ref type="figure" target="#fig_0">1</ref>.</s><s>Significantly increased autoantibodies to three antigens were noted in all three cohorts (A, B and C) with fold changes ranging from 1.1 to 1.5 as detailed in Table <ref type="table" target="#tab_2">3</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In the current study, we set out to identify new diagnostic markers in RA with the use of an extensive screening for IgG autoantibodies.</s><s>The strength of this study consists in the comprehensive inclusion of a vast number of potential autoantigens and the subsequent narrowing of the candidate list, employing independent patient cohorts.</s><s>Importantly, cohorts B and C represented sera from therapy-naïve patients with early RA, emphasizing the potential significance of our results for early serological diagnosis of the disease.</s><s>Moreover, parts of the analyses focused on seronegative patients, resulting in identification of new interesting targets.</s></p><p><s>The risk of over-fitting the data is inherent in the adopted discovery approach with consideration of over 5800 antigens.</s><s>Larger patient numbers were restricted due to practicability and cost considerations.</s><s>Thus, we concentrated on single antigen performance and had to refrain from testing marker combinations.</s><s>Furthermore, correction for multiple testing would have rendered the discovery approach unpromising a priori.</s><s>Rather than direct diagnostic implications, the reported antigens are therefore considered attractive candidates, subject to improved ELISA-based assay development and subsequent clinical testing.</s><s>The advantages of improved laboratory diagnosis are evident, because 30 % of the RA patient population cannot be identified applying diagnostic testing for ACPA and/or rheumatoid factor (RF) <ref type="bibr" target="#b7">[8]</ref>.</s></p><p><s>We and others assume that a certain percentage of seronegative patients are truly seronegative, i.e. do not generate autoantibodies in the course of the disease, whereas other patients have autoantibodies against so far undisclosed antigens <ref type="bibr" target="#b12">[13]</ref>.</s><s>We further expect that this group of false-negative seronegative patients is heterogeneous, and that detection of low-frequency autoantibodies is required for serological detection.</s><s>Only unmodified antigens were tested and only IgG antibodies were considered in the current study.</s><s>Modifications such as citrullination and carbamylation <ref type="bibr" target="#b13">[14]</ref> carry the potential for better detection rates and may yet unmask a greater proportion of seronegative patients with RA.</s><s>However, we chose to use non-modified proteins (i.e.</s><s>without citrullination, carbamylation or acetylation) as we follow the hypothesis that RA may have several different pathophysiological routes, of which the formation of autoantibodies against post-translational modifications and protein complexes is just one (major) route.</s><s>We find support for this hypothesis in the previous discovery of non-modified antigens such as RA33 (HNRNPA2/B1) and 14-3-3 <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b15">16]</ref>.</s><s>Interestingly, 14-3-3 is an antigen both in unmodified and in citrullinated form <ref type="bibr" target="#b16">[17]</ref>.</s></p><p><s>Similarly, we found vimentin in its native form (as confirmed by tandem mass spectrometry) to be an autoantigen in both cohorts A and B <ref type="bibr" target="#b17">[18]</ref>, and vimentin is known to be a major target of ACPA in its citrullinated form <ref type="bibr" target="#b18">[19]</ref>.</s><s>We further assumed that novel autoantibodies would most likely be present in smaller subsets of patients.</s><s>Low prevalence is a common feature of autoantibodies in other autoimmune diseases: in systemic sclerosis several antigens have been described, which occur with a prevalence between 5 and 10 % (Th/T0, U3RNP, PM/Scl) <ref type="bibr" target="#b19">[20]</ref>, and in systemic lupus over 100 autoantibodies have been published, many of which have a prevalence below 15 % <ref type="bibr" target="#b20">[21]</ref>.</s><s>This makes their discovery difficult, because the ratio between high numbers of antigens used in omicstype screening is already in imbalance to the number of available patient samples.</s><s>This imbalance is further complicated if novel markers are present in only 5-15 % of cases.</s><s>Of note, in the present study, sensitivity of antigens across all group comparisons at a predefined specificity of 90 % was 17.7 ± 7.5 %, ranging from 2 to 41 %.</s><s>Even though the study was designed to identify targets rather than determine their individual diagnostic performance, these results seem promising for individual diagnostic assay development.</s><s>Furthermore, future validation of these diagnostic candidates should be carried out, ideally in early RA and include disease controls such as psoriatic arthritis.</s></p><p><s>Even though we used both established RA (cohorts A) and early RA (cohort B and C) for marker identification with the aim of identifying ubiquitous antigens in RA, the use of more homogeneous cohorts (e.g.</s><s>seronegative patients only, or patients with early RA only) would represent an alternative approach to antigenic target identification.</s><s>Clearly, the population used for screening approaches largely influences the resulting candidates.</s><s>Thus, we maintain that an antibody identification strategy by an omics-type approach should be regarded as a means to reduce the number of potential individual targets.</s><s>This in turn enables targeted individual autoantibody validation studies.</s><s>We found support for this approach in other screening studies which similarly resulted in, albeit different, sets of potential targets <ref type="bibr" target="#b12">[13]</ref>.</s><s>This is probably due to different patient populations in terms of numbers of patients and ethnicity, and differences in the autoantibody identification approach <ref type="bibr" target="#b12">[13]</ref>, amongst other reasons.</s><s>Nevertheless, all screening approaches result in potential targets for further individual testing and carry the potential for future diagnostic improvements, as has elegantly been demonstrated previously <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b21">22]</ref>.</s></p><p><s>After comprehensive screening of over 5800 antigens, we describe 23 potential new diagnostic antigens in RA and 13 for seronegative, early RA.</s><s>As both currently used diagnostic antibodies (e.g.</s><s>RF and ACPA antibodies) are involved in the pathogenesis of RA <ref type="bibr" target="#b3">[4]</ref>, it is interesting to speculate which functionalities the newly identified antigenic targets may have, as this might open up new fields of research into the pathogenesis of RA.</s><s>Some of the antigens found have previously been linked to RA.</s><s>Of the three antigens identified in all groups, increased levels of insulin-like growth factor binding protein 2 (IGFBP2) were found in sera from patients with RA, and these correlate with CRP levels and were speculated to contribute to catabolic states in RA <ref type="bibr" target="#b22">[23]</ref>.</s><s>Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) has previously been associated with RA, systemic lupus erythematosus and mixed connective tissue diseases and other rheumatic diseases <ref type="bibr" target="#b14">[15]</ref>.</s><s>A clear connection between N-acetylglucosamine-1-phosphate transferase (GNPTG) and RA is so far unrecognized.</s></p><p><s>Of the antigens identified specifically in seronegative cohorts, a pathophysiological connection to actin beta (ACTB) is conclusive: autoreactive citrullinated epitopes of beta actin have been identified in synovial fluid in RA <ref type="bibr" target="#b23">[24]</ref>.</s><s>Moreover, pharmacological inhibition of actin cytoskeleton dynamics influences the pathogenicity of fibroblasts in arthritis <ref type="bibr" target="#b24">[25]</ref>.</s><s>A testable hypothesis would thus be that autoantibodies to beta actin might alter the cytoskeleton assembly and functionality of synovial fibroblasts towards an RA phenotype.</s><s>Further, plasma kallikrein (antibodies to the beta subunit (KLKB1) were identified) is part of a cascade that results in the activation of bradykinins, which are considered to be potent inflammatory mediators with relevance in arthritis <ref type="bibr" target="#b25">[26]</ref>.</s></p><p><s>Of the intersecting antigens identified in the mixed cohorts A and B, gelsolin (GSN) was recently identified as a promising urinary biomarker for RA <ref type="bibr" target="#b26">[27]</ref>.</s><s>Increased levels of apolipoprotein A4 (APOA4) have been identified in sera from patients with RA using a proteomic approach <ref type="bibr" target="#b27">[28]</ref>.</s><s>Decreased levels of proline-rich acidic proteins have been identified in patients with RA reporting oral sicca symptoms <ref type="bibr" target="#b28">[29]</ref>.</s><s>The roles of the respective antibodies, like PRAP1-antibodies, have not been investigated in this regard so far.</s><s>Moreover, dynactin 1 (DCTN1) has been shown to be an integral part of osteoclast formation and function <ref type="bibr" target="#b29">[30]</ref>.</s><s>Finally, even though antibodies to SSB are a hallmark of Sjögren's syndrome, these antibodies are also found in RA <ref type="bibr" target="#b30">[31]</ref>.</s></p><p><s>The identified antibodies to these known targets deserve further functional studies to determine their potential role in the pathogenesis of RA.</s><s>Of note, most of the antigenic targets identified have not been thoroughly investigated in the context of RA and may thus open up new fields of research.</s><s>Future studies will adopt the challenge of largescale screening for post-translationally modified antigens, and to assess the individual performance of the retrieved candidates.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>Comprehensive sequential autoantibody profiling revealed novel, highly interesting, IgG-autoantibodies for future diagnostic assay development and pathophysiological research, especially in seronegative RA.</s></p><p><s>Abbreviations ACPA: anti-citrullinated peptide antibodies; ACR: American College of Rheumatology; ACTB: actin beta; APOA4: apolipoprotein A4; BBA: bead-based assay; BSA: bovine serum albumin; DAS28: Disease Activity Score for 28 joints; ELISA: enzyme-linked immunosorbent assay; EULAR: European League Against Rheumatism; GNPTG: N-acetylglucosamine-1-phosphate transferase; GSN: gelsolin; HNRNP: heterogeneous nuclear ribonucleoprotein;</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc><div><p><s>Fig. 1 Intersects of significantly increased IgG-autoantibodies</s></p></div></figDesc><graphic coords="4,65.99,94.85,215.21,229.55" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1</head><label>1</label><figDesc><div><p><s>Intersect of significantly increased IgG-autoantibodies in patients with established RA (cohort A) and early RA (cohort B)</s></p></div></figDesc><table><row><cell>Antigen</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc><div><p><s>Intersect of significantly increased IgG autoantibodies in patients with RA (cohorts A, B, and C)</s></p></div></figDesc><table><row><cell>Antigen</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2</head><label>2</label><figDesc><div><p><s>Intersect of significantly increased IgG-autoantibodies in independent cohorts of patients with seronegative RA (cohorts B-and C) Cohort B-: seronegative rheumatoid arthritis (RA) (n = 51).</s><s>Cohort C: patients with seronegative RA (n = 184).</s><s>P is p value for fold change (FC) and sensitivity (S) at 90 % specificity compared to matched healthy controls, according to the Mann-Whitney test IGFBP: insulin-like growth factor binding protein; KLK: plasma kallikrein; MFI: mean fluorescence activity; PBS: phosphate-buffered saline; PRAP: proline-rich acidic proteins; RA: rheumatoid arthritis; RF: rheumatoid factor; RT: room temperature; TNF: tumor necrosis factor</s></p></div></figDesc><table><row><cell>Antigen</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Cohort A: established rheumatoid arthritis (RA) (n = 72). Cohort B: early RA (n = 116). P is p value for fold change (FC) and sensitivity (S) at 90 % specificity compared to matched healthy controls, according to the Mann-Whitney test</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Cohort A: patients with established rheumatoid arthritis (RA) (n = 72). cohort B: early RA (n = 116). cohort C: early seronegative RA (n = 184). P is p value for fold change (FC) and sensitivity (S) at 90 % specificity compared to matched healthy controls, according to the Mann-Whitney test</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>The authors are grateful for the technical assistance of Petra Rengers for the processing of serum samples, Martin Gamer for antigen production and Daniel Chamrad, Laura Schlieker and Klaus Marquart for assistance with data analysis.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Funding SV, RB, RFB, JR, EB and MS gratefully acknowledge financial support from the Hiller Foundation.</s><s>Antigen production was in part funded by grant CLIB2021, 0316041A.</s><s>Parts of the study (HIT HARD) were supported by the German Ministry of Education and Science (BMBF).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Availability of supporting data</head><p><s>Not applicable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' contributions</head><p><s>SV conceived the study, generated clinical data, analyzed data, interpreted data and drafted the manuscript.</s><s>AL conceived the study, generated biomarker data, analyzed data and interpreted data.</s><s>PB generated biomarker data and analyzed data.</s><s>HDZ performed statistical analysis and analyzed data.</s><s>HG generated biomarker data and analyzed data.</s><s>RB participated in statistical analysis, data analysis and data interpretation.</s><s>RFB, JR, EB, JD, H-EL, AS and G-RB generated clinical data and interpreted data.</s><s>PSK and MS conceived the study, analyzed and interpreted data and drafted the manuscript.</s><s>All authors read, critically revised and approved the final version of the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' information Not applicable.</head><p><s>Competing interests AL, PB, HDZ, HG and PSK are employees of Protagen AG, Germany.</s><s>The other authors declare that they have no competing interests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consent for publication</head><p><s>Not applicable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethical approval and consent to participate</head><p><s>Informed patient consent was obtained from all patients and the study was approved by the Ethics Committee of the Medical Faculty of Heinrich Heine University Düsseldorf (study number 2850) and by the Ethics Committee of the Bavarian Medical Chamber (Bayrische Ärztekammer, study number 01/09).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author details</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The pathogenesis of rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Mcinnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">365</biblScope>
			<biblScope unit="page" from="2205" to="2219" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor</title>
		<author>
			<persName><forename type="first">B</forename><surname>Vander Cruyssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Peene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cantaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Iea</forename><surname>Hoffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>De Rycke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Veys</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Autoimmun Rev</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="468" to="474" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">New autoantibodies in early rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Charpin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Arnoux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Toussirot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Balandraud</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Res Ther</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">R78</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin</title>
		<author>
			<persName><forename type="first">U</forename><surname>Harre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Georgess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bozec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Axmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ossipova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="1791" to="1802" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kleyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Finzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rech</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Manger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Krieter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Faustini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Araujo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Hueber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Harre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Engelke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="854" to="860" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">Ahm</forename><surname>Van Der Helm-Van</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Verpoort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Breedveld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rem</forename><surname>Toes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Twj</forename><surname>Huizinga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Res Ther</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="R949" to="958" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Levels of anticitrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ursum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Bos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Van Dillen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Dijkmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Van Schaardenburg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Res Ther</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">R8</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Detert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bastian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Listing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Weiß</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wassenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Liebhaber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="844" to="850" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">A method for global protein expression and antibody screening on highdensity filters of an arrayed cDNA library</title>
		<author>
			<persName><forename type="first">K</forename><surname>Büssow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cahill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Nietfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bancroft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Scherzinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lehrach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="5007" to="5008" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Human ORFeome version 1.1: a platform for reverse proteomics</title>
		<author>
			<persName><forename type="first">J-F</forename><surname>Rual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hirozane-Kishikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bertin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dricot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="2128" to="2135" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product</title>
		<author>
			<persName><forename type="first">U</forename><surname>Brinkmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Mattes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Buckel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="109" to="114" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">A comparison of normalization methods for high density oligonucleotide array data based on variance and bias</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Bolstad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Irizarry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Astrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Speed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinforma Oxf Engl</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="185" to="193" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Novel autoantibody markers for early and seronegative rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Somers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Geusens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Elewaut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Keyser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rummens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-L</forename><surname>Coenen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Autoimmun</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="33" to="46" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage</title>
		<author>
			<persName><forename type="first">J</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Knevel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Suwannalai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Van Der Linden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gmc</forename><surname>Janssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Van Veelen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="17372" to="17377" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases</title>
		<author>
			<persName><forename type="first">G</forename><surname>Steiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Skriner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Smolen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Arch Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="314" to="319" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">14-3-3η: a novel biomarker platform for rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Maksymowych</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Marotta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Rheumatol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="35" to="39" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">SAT0036 Auto-Antibodies to pan and citrullinated 14-3-3 ETA are expressed in anti-CCP negative RA</title>
		<author>
			<persName><forename type="first">A</forename><surname>Maksymowych</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bykerk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Van Der Heijde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Landewé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Marotta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">A592</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Antibodies to vimentin intermediate filaments in sera from patients with SLE and RA: quantitation by solid phase radioimmunoassay</title>
		<author>
			<persName><forename type="first">A</forename><surname>Alcover</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ramirez-Lafita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nieto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Avila</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="233" to="236" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Vossenaar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Després</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lapointe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Van Der Heijden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Senshu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Res Ther</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="R142" to="150" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Update on autoantibodies in systemic sclerosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Fritzler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="580" to="591" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Sherer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gorstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Fritzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shoenfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="501" to="537" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">De</forename><surname>Winter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wlj</forename><surname>Van Steenbergen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Geusens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lenaerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Somers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rheumatology</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1431" to="1436" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Changes in systemic levels of insulin-like growth factors and their binding proteins in patients with rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Neidel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Rheumatol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="81" to="84" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and β-actin</title>
		<author>
			<persName><forename type="first">Jjbc</forename><surname>Van Beers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Schwarte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stammen-Vogelzangs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Oosterink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Božič</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gjm</forename><surname>Pruijn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="69" to="80" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Actin cytoskeleton dynamics linked to synovial fibroblast activation as a novel pathogenic principle in TNF-driven arthritis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Vasilopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gkretsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Armaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Aidinis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kollias</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="23" to="28" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Kallikrein cascade and cytokines in inflamed joints</title>
		<author>
			<persName><forename type="first">B</forename><surname>Cassim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mody</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bhoola</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol Ther</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="1" to="34" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Identification of urinary peptide biomarkers associated with rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Stalmach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Johnsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Mcinnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Husi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dakna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e104625</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Screening diseaseassociated proteins from sera of patients with rheumatoid arthritis: a comparative proteomic study</title>
		<author>
			<persName><forename type="first">T</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Liao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chin Med J (Engl)</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="537" to="543" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Characteristics of rheumatoid arthritis patients with self-reported sicca symptoms: evaluation of medical, salivary and oral parameters</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Uhlig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Kvien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Axéll</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oral Dis</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="254" to="261" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Disruption of the dynein-dynactin compex unveils motor-specific functions in osteoclast formation and bone resorption</title>
		<author>
			<persName><forename type="first">C</forename><surname>Ng Py</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sm</forename><surname>Ang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Khor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Bone Min Res</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="119" to="134" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Detection of human-specific anti-la(SSB) antibodies in patients with rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Manoussakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Kistis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Aidinis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Guialis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Piha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Sekeris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Autoimmun</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="959" to="969" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
